当前位置:首页 - 行情中心 - 华大基因(300676) - 财务分析 - 现金流量表

华大基因

(300676)

  

流通市值:156.48亿  总市值:157.62亿
流通股本:4.11亿   总股本:4.14亿

现金流量表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金4,907,751,773.513,584,309,809.632,448,099,733.11,480,883,694.28
收到的税费返还29,369,879.2223,904,404.9819,977,850.4317,798,587.73
收到其他与经营活动有关的现金194,614,881.91176,040,886.65109,229,062.2150,273,893.21
经营活动现金流入的平衡项目0000
经营活动现金流入小计5,131,736,534.643,784,255,101.262,577,306,645.741,548,956,175.22
购买商品、接受劳务支付的现金1,946,420,301.681,515,900,082.581,072,559,388.05575,998,182.2
支付给职工以及为职工支付的现金1,328,746,612.591,050,773,258.03733,619,691.93518,507,882.67
支付的各项税费174,173,341.2118,745,406.02101,262,941.7876,391,642.83
支付其他与经营活动有关的现金1,273,628,427.8916,710,977.22661,752,290.81354,881,275.49
经营活动现金流出的平衡项目0000
经营活动现金流出小计4,722,968,683.273,602,129,723.852,569,194,312.571,525,778,983.19
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额408,767,851.37182,125,377.418,112,333.1723,177,192.03
二、投资活动产生的现金流量:
收回投资收到的现金3,332,077,841.452,559,015,173.051,829,015,173.051,040,843,660.53
取得投资收益收到的现金240,245,823.66230,408,727.84196,915,554.6109,794,379.14
处置固定资产、无形资产和其他长期资产收回的现金净额2,716,45047,179.751,955.08338.46
收到的其他与投资活动有关的现金11,736,557.697,113,191.726,892,536.451,128,556.8
投资活动现金流入的平衡项目0000
投资活动现金流入小计3,586,776,672.82,796,584,272.362,032,825,219.181,151,766,934.93
购建固定资产、无形资产和其他长期资产支付的现金1,236,385,209.3945,821,053.49522,483,929.6239,954,994.56
投资支付的现金4,095,787,296.211,917,850,772.711,458,457,217.11770,847,217.11
支付其他与投资活动有关的现金5,344,949.777,297,834.927,077,179.651,128,556.8
投资活动现金流出的平衡项目0000
投资活动现金流出小计5,337,517,455.282,870,969,661.121,988,018,326.361,011,930,768.47
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,750,740,782.48-74,385,388.7644,806,892.82139,836,166.46
三、筹资活动产生的现金流量:
吸收投资收到的现金-5,000,000--
取得借款收到的现金251,678,162.82239,234,247.12150,000,000-
收到其他与筹资活动有关的现金82,850,551.84115,324,066115,324,066115,324,066
筹资活动现金流入平衡项目0000
筹资活动现金流入小计334,528,714.66359,558,313.12265,324,066115,324,066
偿还债务支付的现金12,000,0006,000,000--
分配股利、利润或偿付利息支付的现金416,734,734.9415,419,983.01414,258,316.3442,857,143
支付其他与筹资活动有关的现金172,676,186.77152,130,995.97126,837,007.3212,107,977.44
筹资活动现金流出平衡项目0000
筹资活动现金流出小计601,410,921.67573,550,978.98541,095,323.6654,965,120.44
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-266,882,207.01-213,992,665.86-275,771,257.6660,358,945.56
四、汇率变动对现金及现金等价物的影响32,822,168.0370,166,392.96100,418,411.53-47,886,196.67
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,576,032,970.09-36,086,284.25-122,433,620.14175,486,107.38
加:期初现金及现金等价物余额5,131,174,047.075,131,174,047.075,129,191,988.865,129,191,988.86
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,555,141,076.985,095,087,762.825,006,758,368.725,304,678,096.24
补充资料:
净利润93,681,843.43-51,919,525.71-
资产减值准备96,273,989.03-14,656,502.42-
固定资产和投资性房地产折旧312,206,699.84-155,920,186.33-
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧312,206,699.84-155,920,186.33-
无形资产摊销57,607,586.97-35,375,541.28-
长期待摊费用摊销36,145,952.84-16,428,888.41-
处置固定资产、无形资产和其他长期资产的损失-2,763,827.65--1,860,385.38-
固定资产报废损失5,711,218.48-2,835,488.58-
公允价值变动损失34,357,341.9-35,915,976.59-
财务费用66,676,273.68-6,292,675.81-
投资损失-1,284,630.6--29,753,967.21-
递延所得税24,938,090.76--23,488,488.88-
其中:递延所得税资产减少15,316,543.17--8,972,897.94-
递延所得税负债增加9,621,547.59--14,515,590.94-
存货的减少103,781,748.13-117,000,987.96-
经营性应收项目的减少736,488,070.75-362,166,907.59-
经营性应付项目的增加-1,344,884,203.19--772,132,818.43-
其他122,809,861.85---
债务转为资本46,494,875---
不涉及现金收支的投资和筹资活动金额其他项目41,710,934---
现金的期末余额3,555,141,076.98-5,006,758,368.72-
减:现金的期初余额5,131,174,047.07-5,129,191,988.86-
公告日期2024-04-132023-10-282023-08-122023-04-26
审计意见(境内)标准无保留意见
TOP↑